Plus Therapeutics(PSTV) - Prospectus

Table of Contents As filed with the Securities and Exchange Commission August 9, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 Andrew Sims Chief Financial Officer Plus Therapeutics, Inc. 4200 Marathon Blvd., Suite 200 Austin, TX 78756 (737)-255-7194 (Name, address, including zip code, and telephone number, including area code, of agent for service) PLUS THERAPEUTICS, INC. (Exact name of Regi ...